Dec 31, 2015

ANI Pharmaceuticals Q4 2015 Earnings Report

Total Revenue
$18M
Previous year: $21M
-14.3%
EPS
$0.52
Previous year: $1.94
-73.2%
Gross Profit
$14.5M
Previous year: $17.4M
-16.5%
Cash and Equivalents
$155M
Previous year: $169M
-8.5%
Free Cash Flow
$3.6M
Previous year: $10.4M
-65.4%
Total Assets
$285M
Previous year: $260M
+9.9%

ANI Pharmaceuticals

ANI Pharmaceuticals